Yale professor ’s ‘superhuman’ drug treatment attracts investors

Demetrios Braddock ’s research, which uses enzymes to treat a rare disease impacting infants, is going to market with the help of Inozyme Pharmaceuticals.

Source: Yale Science and Health News - January 16, 2018 Category: Universities & Medical Training Source Type: news